Healthcare >> CEO Interviews >> September 13, 2002
DAVID M. CLAPPER has served as President and Chief Executive Officer as
well as a Director of Novacept since November 1999. Prior to joining
Novacept he was President and Chief Executive Officer and a director of
Focal, Inc. Before joining Focal, Mr. Clapper was employed at various
divisions of Johnson & Johnson from 1977 until 1993. He served as Vice
President and a Board Member at Critikon, Inc., a division of Johnson &
Johnson, from 1992 to 1993. From 1977 to 1992, Mr. Clapper held a
variety of positions, including Vice President of Sales and Marketing
and Board Member of Ethicon Endo-Surgery, a division of Johnson &
Johnson, and Vice President of Product Management and Board Member at
Ethicon, Inc. He also serves as a member of the Board of Directors of
Neomend, Inc. Mr. Clapper holds a BS in Marketing from Bowling Green
State University. Profile
and then talk about the present time?
Mr. Clapper: The company was founded in 1995 and was set up to develop a
device for
